A Safety and Efficacy of CCRT With Paclitaxel/Carboplatin as Adjuvant Therapy to Post-operative Cervical Cancer Patients
NCT00340184
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
55
Enrollment
OTHER
Sponsor class
Conditions
Cervical Cancer
Interventions
DRUG:
paclitaxel, carboplatin
Sponsor
Korean Gynecologic Oncology Group